In this webinar, the speakers will discuss the real-world use of PET scans and review the concordance of the PrecivityAD2™ blood test with amyloid PET scans and cerebrospinal fluid (CSF) tests.
Register for this webinar today to understand the critical role of blood biomarkers in Alzheimer’s disease diagnosis and management.
Join Dr. Gil Rabinovici, MD, PhD, Professor, Department of Neurology, Memory & Aging Center, UCSF; and Dr. Joel Braunstein, MD, MBA, Co-Founder and CEO, C2N Diagnostics, for the live webinar on Wednesday, September 4, 2024, at 12pm EDT (9am PDT).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
Although changes in fat distribution from GLP-1 receptor agonist-based therapies are key to understanding many of the health outcome benefits, the impact of skeletal muscle loss on long-term health outcomes remains to be clarified. While skeletal muscle loss is not specific to GLP-1 receptor agonist-based therapies, the degree of weight loss compared to other anti-obesity medications (AOMs) has exposed the limitations of using weight change as a primary endpoint in clinical trials and has highlighted the need for including accurate measurements of changes in muscle mass and function in AOM clinical trials.
The evolving requirement for accurate assessment of body composition (BC) in clinical trials is further driven by:
The variability of changes in fat loss and BC changes to different GLP-1 receptor agonist-based therapies
The variable changes in BC of diverse ethnic and racial populations in response to GLP-1 receptor agonist-based therapies
The expansion of treatment populations by GLP-1 receptor agonist-based therapies to include adolescents with obesity
The development of new therapies aimed at preserving muscle mass and function
Understanding changes in regional adiposity such as pathogenic visceral adipose tissue, liver adipose tissue and epicardial adipose tissue
In this webinar, the speakers will review recent clinical trial data that represents the current state of scientific knowledge and evaluate the impact of the data on loss of muscle mass following GLP-1 receptor agonist-based therapies and the need for accurate and tailored assessments of BC in clinical trials.
Register for this webinar today to delve into the latest clinical trial data on GLP-1 receptor agonist-based therapies and their impact on weight loss and body composition.
Join experts from PPD clinical research business of Thermo Fisher Scientific, Dr. Graham C Ellis, MD, Executive Director, Medical Science and Strategies; Dr. Nathan Ming-Yu Liu, MD, MTM, Associate Medical Director, Pharmacovigilance; and Dr. Donna H. Ryan, MD, Professor Emerita, Pennington Biomedical Research Center, Baton Rouge, Louisiana for the live webinar on Friday, September 6, 2024, at 10am EDT (4pm CEST/EU-Central).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
In this webinar, key considerations for dose selection optimization will be discussed, with a focus on how Project Optimus influences these processes to enhance dose-finding strategies as well as the design constructs of first-in-human trials. Clinical pharmacology considerations will be explored, underscoring the unique pharmacokinetic and pharmacodynamic profiles of radionuclide conjugates and antibody-drug conjugates that differentiate them from traditional small molecules.
Finally, the speakers will share operational considerations for clinical trials, including site selection and meeting patient needs, both of which are critical to the successful execution and progression of trials involving these advanced therapeutic agents. This structured approach aims to provide a clear roadmap for the integrated development and clinical implementation of radionuclide conjugates and antibody-drug conjugates, ensuring their successful transition from research to patient care.
Register for this webinar today to gain a deeper understanding of the transformative potential of antibody-drug conjugates and radionuclide conjugates and learn why they are pivotal in the advancement of precision medicine and significantly improving patient outcomes in oncology.
Join experts from Allucent, Alex MacDonald, PhD, Vice President, Model-Informed Drug Development; Sugato De, MS, Vice President, Regulatory Strategy, Head of Medical Technology, Angela Brady, MHL, Senior Vice President, Global Head of Project Leadership and Client Relations and Dr. Brian Barnett, MD, Executive Medical Director, Oncology for the live webinar on Thursday, September 5, 2024, at 11am EDT (4pm BST/UK).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
The sialylation of antibodies within the Fc domain (at ASN297) regulates the balance between inflammation and tolerance. Non-sialylated antibodies promote inflammation via activation of the Type I Fc receptors, whereas sialylated antibodies reduce inflammation and restore immune self-tolerance via activation of the Type II immunomodulatory Fc receptors DC-SIGN and CD23.
Patients with chronic autoimmune disease commonly present with the low circulating titers of sialylated antibodies, and therefore do not appropriately engage the Type II tolerizing Fc receptors. In this webinar, the expert speakers will discuss a novel therapeutic strategy for the treatment of autoimmune diseases and the administration of a recombinant human IgG1 Fc engineered to agonize the Type II Fc receptors to re-establish normal immune homeostasis.
In this webinar, the experts will also provide some background on how glycosylation is linked to modulating the immune system and how the glycosylation pathways can be engineered for a range of drug development effects, including increasing half-life and bioavailability, enhancing antibody-drug conjugate (ADC) effects and modulating the anti-inflammatory response.
Register for this webinar today to gain insights into the effects of glycosylation on drug efficacy and safety and how engineering glycan profiles can enhance clinical outcomes.
Join Bjørn Voldborg, Head of the National Biologics Facility, Technical University of Denmark (DTU); Greg Coffey, PhD, Co-Founder & Vice President, Immunology & Clinical Translational Research, Nuvig Therapeutics; and Divya Teja Vavilala, PhD, Head of Protein Analytics, ATUM, for the live webinar on Monday, September 9, 2024, at 10am EDT (2pm BST/UK).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
Fresh Tri is a groundbreaking digital health company that helps individuals develop lasting healthy habits through its digital health platform that utilizes Fresh Tri’s proprietary, science-backed Iterative Mindset Method™. Fresh Tri partners with large employers, health systems, and other organizations, enabling their employees and members to benefit from access to the Fresh Tri app, which delivers users resources, including tailored how-to’s, a library of mindset training content, and a health coach.
Founder and CEO of Fresh Tri, Kyra Bobinet, MD, MPH, expressed her excitement for the company’s continued recognition, stating, “We are honored by this recognition and the continued opportunity to empower individuals through Fresh Tri’s proprietary Iterative Mindset MethodTM. As ever, we remain focused on our work to free people from past failure and motivation loss and empower them to build lifelong healthy habits. I’m grateful to our team for their continued work in spreading the word of the Iterative Mindset.”
David Hoke, Managing Director of Fresh Tri’s Institute for Iterative Thinking, remarked, “The work we do at Fresh Tri is having a profound impact on people all over the world. Our continued growth brings the proven benefits of our approach to more people and enables us to continue investing in new research and technologies that will further advance our mission.”
Fresh Tri’s approach is unique in that it works with, instead of against, the brain. With an approach grounded in cutting-edge neuroscience, Fresh Tri is establishing a new standard in behavior change that delivers sustainable health outcomes for everyone.
Fresh Tri launched in 2018 and has experienced consistent growth ever since, landing on the Inc. 5000 every year since 2018. This sustained growth illustrates the company’s unwavering commitment to empowering everyone to form healthy habits and make lasting behavior changes.
Fresh Tri is a 100% employee-owned behavior change organization led by CEO and Founder Dr. Kyra Bobinet. Fresh Tri aims to liberate individuals from failure by teaching healthy habit formation and lasting behavior change. This approach is rooted in Dr. Bobinet’s groundbreaking and neuroscience-backed Iterative Mindset Method™, a practice-and-tweak approach to mindset training and sustainable habits, helping individuals to eat healthy, move more, think positively, and manage stress.
Learn more about Fresh Tri, The Iterative Mindset Method™, and Fresh Tri’s founder at https://freshtri.com/.
Dr. Blight’s book, When Caregiving Calls: Guidance as You Care for a Parent, Spouse, or Aging Relative, has received numerous accolades and is used by caregiver support groups across the world. With a doctoral degree in education, Dr. Blight is also known for his caregiving models which are anchored in learning theory and applied to the unique context of family caregiving.
Dr. Blight’s career path took a turn after the five years he and his wife spent caring for his mother-in-law, who battled cancer before her death in 2005. This experience prompted him to leave CMS and focus on helping individuals and families facing similar caregiving-related challenges.
Dr. Blight joined Shenandoah University as a part-time adjunct professor of healthcare management in 2015 and later transitioned to the public health program. The full-time faculty position represents an expansion of his work in academia. “I’m delighted to become an Assistant Professor of Public Health at Shenandoah University,” said Dr. Blight. “I love it here. The students and faculty are great, and the work is right up my alley.” In addition to teaching more classes at SU, Dr. Blight anticipates continuing his research on caregiving, a growing public health concern in an aging, post-pandemic society.
Aaron Blight, Ed.D., is an international speaker and consultant on caregiving, aging, and healthcare. He is the Founder of Caregiving Kinetics and has been recognized as a “Top 100 Healthcare Leader” by the International Forum on Advancements in Healthcare. His career leading healthcare organizations spans more than two decades and includes the successful creation, development, and sale of a large home care company; a series of policy leadership positions at the Centers for Medicare & Medicaid Services; and the study of caregiving as a phenomenon of social science.
“At ISSA, we recognize the extraordinary commitment that members of the military bring to their service, and we are dedicated to supporting them both during and after their service,” said Rob Findling, ISSA Director of Inside Sales and Military Specialist. “As a Marine Corps veteran, I understand firsthand the transformative power of education and career readiness. This partnership with the VA opens new doors for veterans, allowing them to leverage their discipline and leadership skills into rewarding careers as personal trainers.”
ISSA is a global leader in fitness education, and certification is on a mission to promote healthy living through innovative education. ISSA offers flexible, high-quality programs designed to support fitness professionals at every stage of their career. For active-duty military, ISSA provides Army Credentialing Assistance, which fully funds ISSA personal trainer courses for Active-Duty Army personnel, allowing for skill acquisition without financial burden. These courses enable individuals to gain advanced knowledge in fitness, recovery, and wellness, improving unit readiness and performance. The immediate application of cutting-edge training techniques and health strategies directly to daily routines and mission preparations is another significant benefit.
For active-duty military spouses, the Military Spouse Career Advancement Accounts (MYCAA) program offers reimbursement for eligible military spouses, covering the cost of personal training certification programs at ISSA. Flexible online courses allow for studying at one’s own pace, fitting education around family and other commitments. This makes personal training certifications an ideal career for the mobile military lifestyle, providing employment opportunities anywhere.
Military veterans can benefit from VA funding through the GI Bill, which enables veterans to utilize their educational benefits towards personal training certification programs. ISSA’s programs are designed to help veterans smoothly transition from military service to a rewarding civilian career, leveraging their discipline, leadership, and physical training background to excel as personal trainers. ISSA also offers job placement assistance, including career services and networking opportunities with employers who value military experience.
For more information, contact ISSA Military Representatives by calling 602-834-1774 or emailing [email protected].
About International Sports Sciences Association (ISSA)
International Sports Sciences Association (ISSA), is the global leader in online fitness and wellness certifications. For over 30 years, ISSA has been committed to delivering comprehensive, cognitive, and practical education that’s grounded in industry research. Rooted in Certified Personal Training certifications, ISSA offers over 50 fitness and wellness certifications and specializations, including a Yoga Alliance recognized Yoga 200-Hour Teacher Training Course, Certified Personal Training en Español, Health Coaching, Nutrition, and more. ISSA has educated nearly half a million trainers across 176 countries while driving toward their vision to connect 100 million people to the power of healthy living by 2030.
“C.O.P.S. is beyond grateful to GOVX for continuing their support of law enforcement survivors,” said Dianne Bernhard, C.O.P.S. Executive Director. “Through our partnership, not only are we able to offset the costs of our healing retreats, camps, and other events, but we are also gaining exposure for law enforcement officers who may not yet be aware of the C.O.P.S. mission, and all that we have to offer active and retired officers. Thank you GOVX for all you do to make a difference.”
GOVX is committed to supporting the law enforcement community and the families of the fallen.
“When an officer is lost in the line of duty, the impact felt is immeasurable,” said Alan Cole, GOVX CEO. “For the families of the departed, it’s vital that they have access to the resources and support necessary to move forward in the wake of such tragedy. At GOVX, we solemnly remember those lost and proudly support C.O.P.S. and the law enforcement community through this donation.”
GOVX assists our nation’s finest non-profit organizations through every single order placed on GOVX.com. To support GOVX Gives Back’s charitable initiatives and learn more, visit https://www.govx.com/t/govx-gives-back.
ABOUT GOVX
GOVX is dedicated to serving those who serve our country and communities – military service members, first responders, law enforcement officers, emergency medical professionals, educators, and other government service personnel. With a customizable suite of solutions, GOVX provides leading brands who share in our mission with a unique opportunity to support this deserving audience. Through our flagship e-commerce site, GOVX.com, brands can authentically reach a growing community of 9M+ members with their own storefront. More than 1K trusted brands currently have a storefront on GOVX.com, offering unbeatable deals to those who serve. With our verification app, GOVX ID, brands can easily enable service member discounts within the checkout flow of their own sites. More than 3K brands currently utilize our GOVX ID technology to honor service members. By leveraging GOVX marketing services solutions, brands can effectively amplify their products or services within our engaged and exclusive community and reinforce their support for Americans who make a difference. In addition to providing unmatched value to those who serve, GOVX also donates a portion of every order to non-profits who serve the military and first responder community. To date we have donated more than $1.5M through our GOVX Gives Back initiative. For more information, visit http://www.GOVX.com.
ABOUT C.O.P.S.
Organized in 1984, Concerns of Police Survivors (C.O.P.S.) provides resources to assist in the rebuilding of the lives of surviving families and affected co-workers of law enforcement officers killed in the line of duty as determined by federal criteria. Furthermore, C.O.P.S. provides training to law enforcement agencies on survivor victimization issues and educates the public on the need to support the law enforcement profession and its survivors. To learn more, visit https://www.concernsofpolicesurvivors.org.
InBios’ Strongy Detect™ IgG ELISA has been developed for the qualitative detection of specific IgG antibodies to Strongyloides recombinant antigens in serum. Intended for use only in patients with clinical history, signs or symptoms consistent with Strongyloides infection, positive results from the test provide evidence for exposure to or infection with Strongyloides and must be confirmed by following guidelines from the Centers for Disease Control and Prevention.
“Strongyloidiasis is a neglected tropical disease that is often underdiagnosed or overlooked,” said Syamal Raychaudhuri, PhD, InBios’ Chief Scientific Officer. “We believe this assay will fill the need for efficient and reliable diagnostic testing in the US and abroad for this important emerging infectious disease.”
About InBios: Since 1996, InBios has been a leader in the development of diagnostic tests for emerging infectious diseases and biothreats. Products are designed for superior performance, efficiency and value. These include many FDA market authorized and CE marked assays for arboviruses, parasitic infections, biothreats, and more. InBios continues to anticipate and serve the growing global public health demand. Products in the pipeline include next generation platforms for tick-borne and respiratory diseases. For more information, visit www.inbios.com.
KIC Ventures partnered with Southern Health Lawyers, LLC to enhance corporate compliance beginning in July 2024. This collaboration reinforces KIC Ventures’ prioritized commitment to adhering to healthcare regulations. Southern Health Lawyers, a top healthcare law firm since 2012, will provide expert legal guidance. KIC Ventures continues to meet Sunshine Act requirements and has launched a new platform for employee compliance training.
FORT LAUDERDALE, Fla., Aug. 14, 2024 /PRNewswire-PRWeb/ — KIC Ventures and its affiliates are pleased to announce that, as of July 2024, we have enhanced our corporate compliance efforts by hiring Southern Health Lawyers, LLC.
Southern Health Lawyers, LLC, recognized as a top law firm in healthcare law since 2012, provides specialized legal counsel to navigate the complexities of healthcare regulations. Their attorneys bring comprehensive expertise in various aspects of the healthcare system, including technology, security, and regulatory law at local, state, and federal levels.
